Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in type 1 diabetes

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 3, Issue 4, 2002, Pages 222-242

  Poulsen, Per Løgstrup ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Ambulatory blood pressure; Autonomic function; Circadian blood pressure variation; Nephropathy; Type 1 diabetes

Indexed keywords

ALBUMIN; ALDOSTERONE; ANTIHYPERTENSIVE AGENT; ARGIPRESSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN;

ADULT; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEART FUNCTION; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BLOOD FLOW; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; QT INTERVAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; URINARY EXCRETION; VAGUS NERVE;

EID: 0036986369     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2002.044     Document Type: Review

References (295)

1. Mogensen CE. Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. Scand J Clin Lab Invest 1976;36:383-8.
2. Mogensen CE. Diabetic renal disease: the quest for normotension-and beyond. Diabet Med 1995;12:756-69.
3. Hasslacher C, Stech W, Wahl P, Ritz E. Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1985;28:6-11.
4. Berglund J, Lins LE, Lins PE. Metabolic and blood pressure monitoring in diabetic renal failure. Acta Med Scand 1985;218:401-08.
5. Parving H-H, Hommel E, Mathiesen E et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. BMJ 1988;296:156-60.
6. Rossing P, Hommel E, Smidt UM, Parving H-H. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 1993;42:715-19.
7. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving H-H. Progression of diabetic nephropathy. Kidney Int 2001;59:702-09.
8. Mogensen,CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 1982;285:685-8.
9. Parving H-H, Andersen AR, Smidt UM, Svendsen PA. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1983;1:1175-9.
10. Anderson S, Brenner BM. Influence of antihypertensive therapy on development and progression of diabetic glomerulopathy. Diabetes Care 1988;11:846-9.
11. Parving H-H, Smidt UM, Hommel E et al. Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy. Am J Kidney Dis 1993;22:188-95.
12. Parving H-H, Hommel E. Prognosis in diabetic nephropathy. BMJ 1989;299:230-3.
13. Mathiesen ER, Borch Johnsen K, Jensen DV, Deckert T. Improved survival in patients with diabetic nephropathy. Diabetologia 1989;32:884-6.
14. Hasslacher C, Borgholte G, Ritz E, Wahl P. Impact of hypertension on prognosis in IDDM. Diabet Metab 1989;15:338-42.
15. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983;25:496-501.
16. Krolewski AS, Warram JH, Christlieb AR. The changing natural history of nephropathy in type I diabetes. Am J Med 1985;78:785-94.
17. Kofoed Enevoldsen A, Borch-Johnsen K, Kreiner S, Nerup J, Deckert T. Declining incidence of persistent proteinuria in type 1 (insulin-dependent) diabetic patients in Denmark. Diabetes 1987;36:205-09.
18. Rossing P, Rossing K, Jacobsen P, Parving H-H. Unchanged incidence of diabetic nephropathy in IDDM patients. Diabetes 1995;44:739-43.
19. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 1993;341:1306-09.
20. Tarnow L, Cambien F, Rossing P et al. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995;44:489-94.
21. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;I:1430-2.
22. Parving H-H, Oxenboll B, Johansen K et al. Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol Copenh 1982;100:500-05.
23. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984;311:89-93.
24. Mathiesen ER, Oxenboll B, Johansen K, Svendsen PA, Deckert T. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1984;26:406-10.
25. Mogensen CE. Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 1999;42:263-85.
26. Caramori ML, Fioretto P, Mauer M. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes 2000;49:1399-408.
27. Wiseman M, Viberti G, Mackintosh D, Jarrett RJ, Keen H. Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1984; 26:401-05.
28. Feldt Rasmussen B, Borch-Johnsen K, Mathiesen ER. Hypertension in diabetes as related to nephropathy. Early blood pressure changes. Hypertension 1985;7:II18-II20.
29. Hansen KW, Christensen CK, Andersen PH, Pedersen MM, Christiansen JS, Mogensen CE. Ambulatory blood pressure in microalbuminuric type 1 diabetic patients. Kidney Int 1992;41:847-54.
30. Hansen KW, Mau Pedersen M, Marshall SM, Christiansen JS, Mogensen CE. Circadian variation of blood pressure in patients with diabetic nephropathy. Diabetologia 1992; 35:1074-9.
31. Moore WV, Donaldson DL, Chonko AM, Ideus P, Wiegmann TB. Ambulatory blood pressure in type I diabetes mellitus. Comparison to presence of incipient nephropathy in adolescents and young adults. Diabetes 1992;41:1035-41.
32. Benhamou PY, Halimi S, De Gaudemaris R et al. Early disturbances of ambulatory blood pressure load in normotensive type I diabetic patients with microalbuminuria. Diabetes Care 1992;15:1614-19.
33. Berrut G, Hallab M, Bouhanick B, Chameau AM, Marre M, Fressinaud P. Value of ambulatory blood pressure monitoring in Type I (Insulin-Dependent) diabetic patients with incipient diabetic nephropathy. Am J Hypertens 1994;7:222-7.
34. Poulsen PL, Ebbehøj E, Hansen KW, Mogensen CE. Elevated ambulatory blood pressure in microalbuminuric IDDM patients is inversely related with renal plasma flow - a compensatory mechanism? Diabetes Care 1997;20:429-32.
35. Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 1988; 297:1092-5.
36. Rudberg S, Aperia A, Freyschuss U, Persson B. Enalapril reduces microalbuminuria in young nortmotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia 1990;33:470-6.
37. Mathiesen ER, Hommel E, Giese J, Parving H-H. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ 1991;303:81-7.
38. Viberti G, Mogensen CE, Groop LC, Pauls JF. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. JAMA 1994;271:275-9.
39. The EUCLID Study Group. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997;349:1787-92.
40. Mathiesen ER, Hommel E, Hansen HP, Smidt UM, Parving H-H. Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. BMJ 1999;319:24-5.
41. Rudberg S, Østerby R, Bangstad HJ, Dahlquist G, Persson B. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus. Diabetologia 1999;42:589-95.
42. Microalbuminuria Collaborative Study Group, UK: Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. BMJ 1993;306:1235-9.
43. Poulsen PL, Hansen KW, Mogensen CE. Ambulatory blood pressure in the transition from normo- to microalbuminuria. A longitudinal study in IDDM patients. Diabetes 1994;43:1248-53.
44. Mathiesen ER, Ronn B, Storm B, Foght H, Deckert T. The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study. Diabet Med 1995;12:482-7.
45. Voros P, Lengyel Z, Nagy V, Nemeth C, Rosivall L, Kammerer L. Diurnal blood pressure variation and albuminuria in normotensive patients with insulin-dependent diabetes mellitus. Nephrol Dial Transplant 1998;13:2257-60.
46. Mølgaard H, Christensen PD, Sørensen KE, Christensen CK, Mogensen CE. Association of 24-h cardiac parasympathetic activity and degree of nephropathy in IDDM patients. Diabetes 1992;41:812-17.
47. Mølgaard H, Christensen PD, Hermansen K, Sørensen KE, Christensen CK, Mogensen CE. Early recognition of autonomic dysfunction in microalbuminuria: significance for cardiovascular mortality in diabetes mellitus? Diabetologia 1994;37:788-96.
48. Jensen T, Stender S, Deckert T. Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 1988;31:142-5.
49. Jones SL, Close CF, Mattock MB, Jarrett RJ, Keen H, Viberti GC. Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. BMJ 1989;298:487-90.
50. Jensen T, Bjerre Knudsen J, Feldt Rasmussen B, Deckert T. Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1989;1:461-3.
51. Stehouwer CD, Stroes ES, Hackeng WH, Mulder PG, den Ottolander GJ. von Willebrand factor and development of diabetic nephropathy in IDDM (published erratum appears in Diabetes 1991 Dec;40[12]:1746). Diabetes 1991;40:971-6.
52. Dogra G, Rich L, Stanton K, Watts GF. Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria. Diabetologia 2001;44:593-601.
53. Chavers BM, Mauer SM, Ramsay RC, Steffes MW. Relationship between retinal and glomerular lesions in IDDM patients. Diabetes 1994;43:441-6.
54. Ekbom P, Damm P, Nogaard K et al. Urinary albumin excretion and 24-hour blood pressure as predictors of pre-eclampsia in Type I diabetes. Diabetologia 2000;43:927-31.
55. Bangstad, HJ, Østerby R, Dahl Jorgensen,K et al. Early glomerulopathy is present in young, Type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1993;36:523-9.
56. Østerby R, Bangstad HJ, Nyberg G, Walker JD, Viberti GC. A quantitative ultrastructural study of juxtaglomerular arterioles in IDDM patients with micro- and normoalbuminuria. Diabetologia 1995;38:1320-7.
57. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000;35:898-903.
58. O'Brien IA, McFadden JP, Corrall RJ. The influence of autonomic neuropathy on mortality in insulin- dependent diabetes. Q J Med 1991;79:495-502.
59. Winocour PH, Dhar H, Anderson DC. The relationship between autonomic neuropathy and urinary sodium and albumin excretion in insulin-treated diabetics. Diabet Med 1986;3:436-40.
60. Bell GM, Reid W, Ewing DJ, Cumming AD, Watson ML, Doig A, Clarke BF. Abnormal diurnal urinary sodium and water excretion in diabetic autonomic neuropathy. Clin Sci 1987; 73:259-65.
61. Sundkvist G, Lilja B. Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM. Diabetes Care 1993;16:773-9.
62. Spallone V, Gambardella S, Maiello MR, Barini A, Frontoni S, Menzinger G. Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients. Diabetes Care 1994;17:578-84.
63. Monteagudo PT, Nóbrega, JC, Cezarini PR et al. Altered blood pressure profile, autonomic neuropathy and nephropathy in insulin dependent diabetic patients. Eur J Endocrinol 1996;135:683-8.
64. Mogensen CE, Chachati A, Christensen CK et al. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 1985;9:85-95.
65. Poulsen PL, Ebbehøj E, Hansen KW, Mogensen CE. 24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients. Diabetologia 1997;40:718-25.
66. Poulsen PL, Hansen KW, Ebbehøj E, Knudsen ST, Mogensen CE. No deleterious effects of tight blood glucose control on 24 h ambulatory blood pressure in normoalbuminur-ic IDDM patients. J Clin Endocrinol Metab 2000;85:155-8.
67. Poulsen PL, Ebbehøj E, Arildsen H et al. Increased QTc dispersion is related to blunted circadian blood pressure variation in normoalbuminuric type 1 diabetic patients. Diabetes 2001;50:837-42.
68. Gatling W, Knight C, Mullee MA, Hill RD. Microalbuminuria in diabetes: a population study of the prevalence and an assessment of three screening tests. Diabet Med 1988;5:343-7.
69. Poulsen PL, Ebbehøj E, Nosadini R et al. Early ACE-i intervention in microalbuminuric patients with type 1 diabetes: Effects on albumin excretion, 24 h ambulatory blood pressure, and renal function. Diabetes and Metab 2001;27:123-8.
70. Poulsen PL, Ebbehøj E, Mogensen CE. Lisinopril reduces albuminuria during exercise in low grade microalbuminuric Type 1 diabetic patients: A double blind randomized study. J Intern Med 2001;249:433-40.
71. Feldt Rasmussen B, Mathiesen ER. Variability of urinary excretion in incipient diabetic nephropathy. Diabetic Nephropathy 1984;3:101-03.
72. Mogensen CE, Vestbo E, Poulsen PL et al. Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion. Diabetes Care 1995;18:572-81.
73. Posey JA, Geddes LA, Williams H, Moore AG. The meaning of the point of maximum oscillations in cuff pressure in the indirect measurement of blood pressure. 1. Cardiovasc Res Cent Bull 1969;8:15-25.
74. Ramsey M. Noninvasive automatic determination of mean arterial pressure. Med Biol Eng Comput 1979;17:11-18.
75. Hansen KW, Ørskov H. A plea for consistent reliability in ambulatory blood pressure monitors: a reminder. J hypertens 1992;10:1313-15.
76. Hansen KW, Christiansen JS. Research methodologies for recording blood pressure in diabetic patients. In: Research methodologies in human diabetes. Mogensen CE and Standl E (eds.). Berlin; New York, De Gruyter, 1995;p. 113-124.
77. O'Brien E, Petrie J, Littler W et al. The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special reference to ambulatory systems. J Hypertens 1990;8:607-19.
78. O'Brien E, Mee F, Atkins N, O'Malley K. Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society protocol. J Hypertens 1991;9:573-4.
79. O'Brien E, Mee F, Atkins N, O'Malley K. Evaluation of the Spacelabs 90202 according to the AAMI standard and the BHS criteria. J Hum Hypertens 1991;5:223-6.
80. Hansen KW, Poulsen PL, Mogensen CE. Ambulatory blood pressure and abnormal albuminuria in type 1 diabetic patients. Kidney Int 1994;suppl 45:S134-S140.
81. Capani F, Basile S, Guagnano MT, Ramoni L, Sensi S. Can the chronobiological approach better evaluate the relationship between diabetes mellitus and arterial hypertension? Prog Clin Biol Res 1990;341A:403-09.
82. Nakano S, Uchida K, Kigoshi T et al. Circadian rhythm of blood pressure in normotensive NIDDM subjects. Its relationship to microvascular complications. Diabetes Care 1991;14:707-11.
83. Germano G, Damiani S, Caparra A et al. Ambulatory blood pressure recording in diabetic patients with abnormal responses to cardiovascular autonomic function tests. Acta Diabetol 1992;28:221-8.
84. Hansen KW, Poulsen PL, Christiansen JS, Mogensen CE. Determinants of 24-h blood pressure in IDDM patients. Diabetes Care 1995;18:529-35.
85. Wiinberg N, Hoegholm A, Christensen HR et al. 24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens 1995;8:978-86.
86. Schwan A, Eriksson G. Effect on sleep-but not on blood pressure-of nocturnal non-invasive blood pressure monitoring. J Hypertens 1992;10:189-94.
87. Parati G, Pomidossi G, Casadei R et al. Ambulatory blood pressure monitoring does not interfere with the haemodynamic effects of sleep. J Hypertens 1985;suppl 3:S107-S109.
88. Parati G, Pomidossi G, Casadei R, Mancia G. Lack of alerting reactions to intermittent cuff inflations during noninvasive blood pressure monitoring. Hypertension 1985;7:597-601.
89. Brigden G, Broadhurst P, Cashman P, Raftery EB. Effects of noninvasive ambulatory blood pressure measuring devices on blood pressure. Am J Cardiol 1990;66:1396-8.
90. Villani A, Parati G, Groppelli A, Omboni S, Di Rienzo M, Mancia G. Noninvasive automatic blood pressure monitoring does not attenuate nighttime hypotension. Evidence from 24 h intraarterial blood pressure monitoring. Am J Hypertens 1992;5:744-7.
91. Degaute JP, van de BP, Kerkhofs M, Dramaix M, Linkowski P. Does non-invasive ambulatory blood pressure monitoring disturb sleep? J Hypertens 1992;10:879-85.
92. Davies RJ, Jenkins NE, Stradling JR. Effect of measuring ambulatory blood pressure on sleep and on blood pressure during sleep. BMJ 1994;308:820-23.
93. Thordarson H, Thorgeirsson G, Helgason T. Aortic stiffness in insulin-dependent diabetics: an echocardiographic study. Diabet Med 1986;3:449-54.
94. Oxlund H, Rasmussen LM, Andreassen TT, Heickendorff L. Increased aortic stiffness in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1989;32:748-52.
95. Hansen KW, Pedersen MM, Christiansen JS, Mogensen CE. Diurnal blood pressure variations in normoalbuminuric type 1 diabetic patients. J Intern Med 1993;234:175-80.
96. van Ittersum FJ, Wijering RM, Lambert J, Donker AJ, Stehouwer CD. Determinants of the limits of agreement between the sphygmomanometer and the SpaceLabs 90207 device for blood pressure measurement in health volunteers and insulin-dependent diabetic patients. J Hypertens 1998;16:1125-30.
97. Mauck GW, Smith CR, Geddes LA, Bourland JD. The meaning of the point of maximum oscillations in cuff pressure in the indirect measurement of blood pressure-part ii. J Biomech Eng 1980;102:28-33.
98. Mogensen CE. Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Lab Invest 1971;28:91-100.
99. Hansen KW, Mau Pedersen M, Christensen CK, Schmitz A, Christiansen JS, Mogensen CE. Normoalbuminuria ensures no reduction of renal function in type 1 (insulin-dependent) diabetic patients. J Intern Med 1992;232:161-7.
100. Mogensen CE, Hansen KW, Nielsen S, Pedersen MM, Rehling M, Schmitz A. Monitoring diabetic nephropathy: Glomerular filtration rate and abnormal albuminuria in diabetic renal disease - reproduceability, progression and efficacy of antihypertensive intervention. Am J Kidney Dis 1993;22:174-87.
101. Sallinger J, Vychodil R, Pumprla J et al. Telemetric computer-aided system for non-invasive examination of heart rate variability, type VariaPulse TF3. Comput Cardiol IEEE Proc 1995;437-40.
102. Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ. Power spectrum analysis of the heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 1981;213:220-2.
103. Pomeranz B, Macaulay RJ, Caudill MA et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985;248:H151-H153.
104. Furlan R, Guzzetti S, Crivellaro W et al. Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation 1990;81:537-47.
105. Hayano J, Sakakibara Y, Yamada A, Yamada M, Mukai S, Fujinami T, Yokoyama K, Watanabe Y, Takata K. Accuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects. Am J Cardiol 1991;67:199-204.
106. Bernardi L, Ricordi L, Lazzari P et al. Impaired circadian modulation of sympathovagal activity in diabetes. A possible explanation for altered temporal onset of cardiovascular disease. Circulation 1992;86:1443-52.
107. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991;84:482-92.
108. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996;17: 354-81.
109. Mancia G, Paleari F, Parati G. Early diagnosis of diabetic autonomic neuropathy: present and future approaches. Diabetologia 1997;40:482-4.
110. Eckberg DL. Sympathovagal balance: a critical appraisal. Circulation 1997;96:3224-32.
111. Ewing DJ, Neilson JM, Shapiro CM, Stewart JA, Reid W. Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients. Br Heart J 1991;65:239-44.
112. Frattola A, Parati G, Gamba P et al. Time and frequency domain estimates of spontaneous baroreflex sensitivity provide early detection of autonomic dysfunction in diabetes mellitus. Diabetologia 1997;40:1470-5.
113. Yamamoto Y, Hughson RL. Coarse-graining spectral analysis: new method for studying heart rate variability. J Appl Physiol 1991;71:1143-50.
114. Ebbehøj E. Effects of metoprolol on cardiac autonomic function and 24-h blood pressure in ACE-inhibitor treated type 1 diabetic patients with abnormal albuminuria. Ph.D. thesis, Aarhus University, 2001
115. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985;8:491-8.
116. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-6.
117. Early treatment for diabetic retinopathy study group: Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS Report number 12. Ophthalmology 1991;98:823-33.
118. Bazett H. An analysis of time-relations of electrocardiograms. Heart 1920;7:353-70.
119. Christensen CK, Ørskov C. Rapid screening PEG radioimmunoassay for quantification of pathological microalbuminuria. Diabetic Nephropathy 1984;3:92-4.
120. Holl RW, Grabert M, Heinze E, Debatin KM. Objective assessment of smoking habits by urinary cotinine measurement in adolescents and young adults with Type 1 diabetes. Reliability of reported cigarette consumption and relationship to urinary albumin excretion. Diabetes Care 1998;21:787-91.
121. Page SR, Manning G, Ingle AR, Hill P, Millar-Craig MW, Peacock I. Raised ambulatory blood pressure in type 1 diabetes with incipient microalbuminuria. Diabet Med 1994; 11:877-82.
122. Hoegholm A, Bang LE, Kristensen KS, Nielsen JW, Holm J. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension. Hypertension 1994;24:101-05.
123. van Ittersum FJ, Spek JJ, Praet IJ et al. Ambulatory blood pressures and autonomic nervous function in normoalbuminuric type I diabetic patients. Nephrol Dial Transplant 1998;13:326-32.
124. Pecis M, Azevedo MJ, Moraes RS, Ferlin, EL, Gross JL. Autonomic dysfunction and urinary albumin excretion rate are associated with an abnormal blood pressure pattern in normotensive normoalbuminuric type 1 diabetic patients. Diabetes Care 2000;23:989-93.
125. Lafferty AR, Werther GA, Clarke CF. Ambulatory blood pressure, microalbuminuria, and autonomic neuropathy in adolescents with type 1 diabetes. Diabetes Care 2000;23:533-8.
126. Near-normal urinary albumin concentrations predict progression to diabetic nephropathy in Type 1 diabetes mellitus. Royal College of Physicians of Edinburgh Diabetes Register Group. Diabet Med 2000;17:782-91.
127. Schultz CJ, Neil HA, Dalton RN, Dunger DB. Risk of nephropathy can be detected before the onset of microalbuminuria during the early years after diagnosis of type 1 diabetes. Oxford Regional Prospective Study Group. Diabetes Care 2000;23:1811-15.
128. Parving H-H, Kastrup H, Smidt UM, Andersen AR, Feldt-Rasmussen B, Christiansen JS. Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 1984;27:547-52.
129. Christensen PK, Hansen HP, Parving H-H. Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients. Kidney Int 1997;52:1369-74.
130. Parving H-H, Viberti GC, Keen H, Christiansen JS, Lassen NA. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 1983;32:943-9.
131. Riser BL, Cortes P, Zhao X, Bernstein J, Dumler F, Narins RG. Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 1992;90:1932-43.
132. Feldt Rasmussen B, Mathiesen ER, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 1986;2:1300-04.
133. Dahl Jorgensen K, Hanssen KF, Kierulf P, Bjoro T, Sandvik L, Aagenaes O. Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study. Acta Endocrinol Copenh 1988;117:19-25.
134. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329:304-09.
135. The Diabetes Control and Complication Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-86.
136. Powrie JK, Watts GF, Ingham JN, Taub NA, Talmud, PJ, Shaw KM. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. BMJ 1994;309:1608-12.
137. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 2000;342:381-9.
138. Azar ST, Birbari A. Nocturnal blood pressure elevation in patients with type 1 diabetes receiving intensive insulin therapy compared with that in patients receiving conventional insulin therapy. J Clin Endocrinol Metab 1998;83:3190-3.
139. Stephenson JM, Fuller JH, Viberti GC, Sjolie AK, Navalesi R. Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study. Diabetologia 1995;38:599-603.
140. Sjolie AK, Stephenson JM, Aldington S et al. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM complications study. Ophthalmology 1997;104:252-60.
141. Poulsen PL, Bek T, Ebbehøj E, Hansen KW, Mogensen CE. 24-h ambulatory blood pressure and retinopathy in normoalbuminuric IDDM patients. Diabetologia 1998;41:105-10.
142. Holl RW, Pavlovic M, Heinze E, Thon A. Circadian blood pressure during the early course of type 1 diabetes. Analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults. Diabetes Care 1999;22:1151-7.
143. Young LA, Kimball TR, Daniels SR et al. Nocturnal blood pressure in young patients with insulin-dependent diabetes mellitus: correlation with cardiac function. J Pediatr 1998;133:46-50.
144. Mathiesen ER, Hilsted J, Feldt-Rasmussen B et al. The effect of metabolic control on hemodynamics in short-term insulin-dependent diabetic patients. Diabetes 1985;34:1301-05.
145. Mathiesen ER, Gall MA, Hommel E, Skott P, Parving H-H. Effects of short-term strict metabolic control on kidney function and extracellular fluid volume in incipient diabetic nephropathy. Diabet Med 1989;6:595-600.
146. Ford ES, Malarcher AM, Herman WH, Auber RE. Diabetes mellitus and cigarette smoking. Findings from the 1989 National Health Interview Survey. Diabetes Care 1994;17:688-92.
147. Malarcher AM, Ford ES, Nelson DE et al.Trends in cigarette smoking and physicians' advice to quit smoking among people with diabetes in the U.S. Diabetes Care 1995;18:694-7.
148. Adlerberth AM, Rosengren A, Wilhelmsen L. Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. A general population study. Diabetes Care 1998;21:539-45.
149. Gordon T, Kannel WB, Dawber TR, McGee D. Changes associated with quitting cigarette smoking: the Framingham Study. Am Heart J 1975;90:322-8.
150. Wilhelmsen L. Coronary heart disease: epidemiology of smoking and intervention studies of smoking. Am Heart J 1988;115:242-9.
151. Rossing P, Hougaard P, Borch-Johnsen K, Parving, H-H. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ 1996;313:779-84.
152. Borch-Johnsen K, Kreiner S. Proteinuria: Value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. BMJ 1987;294:1651-4.
153. Christiansen JS. Cigarette smoking and prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus. Diabetes Care 1978;1:146-9.
154. Nielsen MM, Hjollund E. Smoking and diabetic microangiopathy [letter]. Lancet 1978;2:533-4.
155. Telmer S, Christiansen JS,Andersen AR, Nerup J, Deckert T. Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med Scand 1984;215:63-8.
156. Norden G, Nyberg G. Smoking and diabetic nephropathy. Acta Med Scand 1984;215:257-61.
157. Muhlhauser I, Sawicki P, Berger M. Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in type 1 (insulin-dependent) diabetes. Diabetologia 1986;29:500-02.
158. Ekberg G, Grefberg N, Larsson LO. Cigarette smoking and urinary albumin excretion in insulin-treated diabetics without manifest nephropathy. J Intern Med 1991;230:435-42.
159. Stegmayr BG. A study of patients with diabetes mellitus (type 1) and end-stage renal failure: tobacco usage may increase risk of nephropathy and death. J Intern Med 1990;228:121-4.
160. Chaturvedi N, Stephenson JM, Fuller JH. The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study. Diabetes Care 1995;18:785-92.
161. Karamanos B, Porta M, Songini M et al. Different risk factors of microangiopathy in patients with type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study. Diabetologia 2000;43:348-55.
162. Ritz E, Ogata H, Orth SR. Smoking: a factor promoting onset and progression of diabetic nephropathy. Diabetes Metab 2000;26(suppl 4):54-63.
163. Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. The Microalbuminuria Collaborative Study Group. Diabet Med 1999;16:918-25.
164. Rossing P, Borch-Johnsen K, Parving H-H. Risk factors for development of incipient and overt diabetic nephropathy in IDDM patients. ASN 1993;4(abstract):308.
165. Chase HP, Garg SK, Marshall G, Berg CL, Harris S, Jackson WE, Hamman RE. Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA 1991;265:614-17.
166. Sawicki PT, Didjurgeit U, Muhlhauser I, Bender R, Heinemann L, Berger M. Smoking is associated with progression of diabetic nephropathy. Diabetes Care 1994;17:126-31.
167. Ward MM, Studenski S. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med 1992;152:2082-8.
168. Orth SR, Stockmann A, Conradt C et al. Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 1998;54:926-31.
169. Stengel B, Couchoud C, Cenee S, Hemon D. Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. Kidney Int 2000;57:2519-26.
170. Regalado M, Yang S, Wesson DE. Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension. Am J Kidney Dis 2000;35:687-94.
171. Lundman BM, Asplund K, Norberg A. Smoking and metabolic control in patients with insulin-dependent diabetes mellitus. J Intern Med 1990;227:101-06.
172. Mathiesen ER, Soegaard U, Christiansen JS. Smoking and glycaemic control in male insulin dependent (type 1) diabetics. Diabetes
173. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976;295:573-7.
174. Hansen HP, Rossing K, Jacobsen P, Jensen BR, Parving H-H. The acute effect of smoking on systemic haemodynamics, kidney and endothelial functions in insulin-dependent diabetic patients with microalbuminuria. Scand J Clin Lab Invest 1996;56:393-9.
175. Ritz E, Benck U, Franek E, Keller C, Seyfarth M, Clorius J. Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease. J Am Soc Nephrol 1998;9:1798-804.
176. Karvonen M, Keys A, Orma E, Fidanza F, Brozek J. Cigarette smoking, serum-cholesterol, blood-pressure, and body fatness. Observations in Finland. Lancet 1956;i:492-4.
177. Higgins MW, Kjelsberg M. Characteristics of smokers and nonsmokers in Tecumseh, Michigan. II. The distribution of selected physical measurements and physiologic variables and the prevalence of certain diseases in smokers and nonsmokers. Am J Epidemiol 1967;86:60-77.
178. Seltzer CC. Effect of smoking on blood pressure. Am Heart J 1974;87:558-64.
179. Berglund G, Wilhelmsen L. Factors related to blood pressure in a general population sample of Swedish men. Acta Med Scand 1975;198:291-8.
180. Green MS, Jucha E, Luz Y. Blood pressure in smokers and nonsmokers: epidemiologic findings. Am Heart J 1986;11:932-40.
181. Green MS, Harari G, Schwartz K. Cigarette smoking related to ambulatory blood pressure and heart rate. Am Heart J 1991;121:1569-70.
182. Hansen KW, Pedersen MM, Christiansen JS, Mogensen CE. Night blood pressure and cigarette smoking: disparate association in healthy subjects and diabetic patients. Blood Press 1994;3:381-8.
183. Mikkelsen KL, Wiinberg N, Høegholm A et al. Smoking related to 24-h ambulatory blood pressure and heart rate. A study in 352 normotensive Danish subjects. Am J Hypertens 1997;10:483-91.
184. Mann SJ, James GD, Wang RS, Pickering TG. Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study. JAMA 1991;265:2226-8.
185. Bolinder G, de Faire U. Ambulatory 24-h blood pressure monitoring in healthy, middle-aged smokeless tobacco users, smokers, and nontobacco users. Am J Hypertens 1998;11: 1153-63.
186. Verdecchia P, Schillaci G, Borgioni C et al. Cigarette smoking, ambulatory blood pressure and cardiac hypertrophy in essential hypertension. J Hypertens 1995;13:1209-15.
187. Minami J, Ishimitsu T, Matsuoka H. Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension 1999;33:586-90.
188. Poulsen PL, Ebbehøj E, Hansen KW, Mogensen CE. Effects of smoking on 24-h ambulatory blood pressure and autonomic function in normoalbuminuric insulin-dependent diabetes mellitus patients. Am J Hypertens 1998;11:1093-9.
189. Sinha RN, Patrick AW, Richardson L, MacFarlane IA. Diurnal variation in blood pressure in insulin-dependent diabetic smokers and non-smokers with and without microalbuminuria. Diabet Med 1997;14:291-5.
190. Steiner G. Diabetes and atherosclerosis: an overview. Diabetes 1981;30:1-7.
191. Blacher J, Staessen JA, Girerd X et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000;160:1085-9.
192. Hayano J, Yamada M, Sakakibara Y et al. Short- and long-term effects of cigarette smoking on heart rate variability. Am J Cardiol 1990;65:84-8.
193. Sawicki PT, Muhlhauser I, Bender R, Pethke W, Heinemann L, Berger M. Effects of smoking on blood pressure and proteinuria in patients with diabetic nephropathy. J Intern Med 1996;239:345-52.
194. Moss SE, Klein R, Klein BE. The incidence of vision loss in a diabetic population. Ophthalmology 1988;95:1340-8.
195. Vision problems in the US: Data analysis: Definitions, data sources, detailed data tables, analysis, interpretation. New York, NY: National society to prevent blindness 1980.
196. Backlund LB, Algvere PV, Rosenqvist U. New blindness in diabetes reduced by more than one-third in Stockholm County. Diabet Med 1997;14:732-40.
197. Trautner C, Haastert B, Giani G, Berger M. Incidence of blindness in southern Germany between 1990 and 1998. Diabetologia 2001;44:147-50.
198. Klein R, Klein BE, Moss SE, Cruickshanks KJ. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 1994;154:2169-78.
199. Chase HP, Garg SK, Jackson WE et al. Blood pressure and retinopathy in type I diabetes. Ophthalmology 1990;97:155-9.
200. Knuimann MW, Welborn TA, McCann VJ, Stanton KG, Constable IJ. Prevalence of diabetic complications in relation to risk factors. Diabetes 1986;35:1332-9.
201. Janka HU, Warram JH, Rand LI, Krolewski AS. Risk factors for progression of background retinopathy in long-standing IDDM. Diabetes 1989;38:460-4.
202. Knudsen ST, Poulsen PL, Hansen KW, Ebbehøj E, Bek T, Mogensen CE. Pulse pressure and diurnal blood pressure variation: Association with micro- and macrovascular complications in type 2 diabetes. Diabetes 2001;(suppl) (Abstract).
203. Nielsen S, Schmitz A, Poulsen PL, Hansen KW, Mogensen CE. Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study. Diabetes Care 1995;18:1434-41.
204. Nørgaard K, Feldt Rasmussen B, Deckert T. Is hypertension a major independent risk factor for retinopathy in type 1 diabetes? Diabet Med 1991;8:334-7.
205. Rand LI, Krolewski AS, Aiello LM, Warram JH, Baker RS, Maki T. Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med 1985;313:1433-8.
206. Chaturvedi N, Sjoelie AK, Porta M et al. Markers of insulin resistance are strong risk factors for retinopathy incidence in type I diabetes. Diabetes Care 2001;24:284-9.
207. Dimmitt SB, West JN, Eames SM, Gibson JM, Gosling P, Littler WA. Usefulness of ophthalmoscopy in mild to moderate hypertension. Lancet 1989;1:1103-06.
208. Parving H-H, Larsen M, Hommel E, Lund Andersen H. Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy. Diabetologia 1989;32:440-4.
209. Cowan JC, Yusoff K, Moore M et al. Importance of lead selection in QT interval measurement. Am J Cardiol 1988;61:83-7.
210. Day CP, McComb JM, Campbell RW. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990;63:342-4.
211. Zabel M, Portnoy S, Franz MR. Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study. J Am Coll Cardiol 1995;25:746-52.
212. Langen KJ, Ziegler D, Weise F et al. Evaluation of QT interval length, QT dispersion and myocardial m- iodobenzylguanidine uptake in insulin-dependent diabetic patients with and without autonomic neuropathy. Clin Sci (Colch) 1997;93:325-33.
213. Aytemir K, Aksoyek S, Ozer N, Gurlek A, Oto A. QT dispersion and autonomic nervous system function in patients with type 1 diabetes. Int J Cardiol 1998;65:45-50.
214. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 1991;84:1516-23.
215. Dekker JM, Schouten EG, Klootwijk P, Pool J, Kromhout D. Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study. Circulation 1994;90:779-85.
216. de Bruyne MC, Hoes AW, Kors, JA, Hofman A, van Bemmel JH, Grobbee DE. QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circulation 1998;97:467-72.
217. Elming H, Holm E, Jun L et al. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 1998;19:1391-400.
218. Sawicki PT, Dahne R, Bender R, Berger M. Prolonged QT interval as a predictor of mortality in diabetic nephropathy. Diabetologia 1996;39:77-81.
219. Sawicki PT, Kiwitt S, Bender R, Berger M. The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus. J Intern Med 1998;243:49-56.
220. Naas AA, Davidson NC, Thompson C, Cummings F, Ogston SA, Jung RT, Newton, RW, Struthers, AD. QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study. BMJ 1998;316:745-6.
221. Christensen PK, Gall MA, Major-Pedersen A et al. QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes. Scand J Clin Lab Invest 2000;60:323-32.
222. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990;81:528-36.
223. Palatini P, Penzo M, Racioppa A, Zugno E, Guzzardi G, Anaclerio M, Pessina AC. Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Intern Med 1992;152:1855-60.
224. Verdecchia P, Schillaci G, Gatteschi C, Zampi, I, Battistelli M, Bartoccini C, Porcellati C. Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. Circulation 1993;88:986-92.
225. Staessen JA, Thijs L, Fagard R et al. Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999;282:539-46.
226. Nakano S, Fukuda M, Hotta F et al. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes 1998;47:1501-06.
227. Sturrock ND, George E, Pound N, Stevenson J, Peck GM, Sowter H. Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabet Med 2000;17:360-4.
228. Burger AJ, Weinrauch LA, D'Elia JA, Aronson D. Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy. Am J Cardiol 1999;84:687-91.
229. Kohno I, Takusagawa M, Yin D et al. QT dispersion in dipper- and nondipper-type hypertension. Am J Hypertens 1998:11:280-5.
230. Gryglewska B, Grodzicki T, Czarnecka D, Kawecka-Jaszcz K, Kocemba J. QT dispersion and hypertensive heart disease in the elderly. J Hypertens 2000;18:461-4.
231. Mayet J, Shahi M, McGrath K et al. Left ventricular hypertrophy and QT dispersion in hypertension. Hypertension 1996;28:791-6.
232. Arildsen H, May O, Christiansen EH, Damsgaard EM. Increased QT dispersion in patients with insulin-dependent diabetes mellitus. Int J Cardiol 1999;71:235-42.
233. Yunus A, Gillis AM, Traboulsi M et al. Effect of coronary angioplasty on precordial QT dispersion. Am J Cardiol 1997;79:1339-42.
234. Viberti GC, Keen H, Wiseman MJ. Raised arterial pressure in parents of proteinuric insulin dependent diabetics. BMJ 1987;295:515-17.
235. Krolewski AS, Canessa M, Warram JH et al. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988;318:140-5.
236. Fagerudd JA, Tarnow L, Jacobsen P et al. Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients. Diabetes 1998;47:439-44.
237. Deckert T, Feldt Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed Enevoldsen, A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989;32:219-26.
238. Cooper ME, Frauman A, O'Brien RC, Seeman E, Murray RM, Jerums G. Progression of proteinuria in type 1 and type 2 diabetes (published erratum appears in Diabetic Med 1988 Jul-Aug:5[5]:422). Diabet Med 1988;5:361-8.
239. Mathiesen ER, Ronn B, Jensen T, Storm B, Deckert T. Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria. Diabetes 1990;39:245-9.
240. Raal FJ, Kalk WJ, Taylor DR, Osler CE, Panz VR. The relationship between the development and progression of microalbuminuria and arterial blood pressure in type 1 (insulin-dependent) diabetes mellitus. Diabetes Res Clin Pract 1992;16:221-7.
241. Rudberg S, Persson B, Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathy-an 8-year prospective study. Kidney Int 1992;41:822-8.
242. Gilbert RE, Tsalamandris C, Bach LA et al. Long-term glycemic control and the rate of progression of early diabetic kidney disease. Kidney Int 1993;44:855-9.
243. Coonrod BA, Ellis D, Becker DJ et al. Predictors of Microalbuminuria in Individuals with IDDM. Pittsburg Epidemiology of Diabetes Complication Study Diabetes Care 1993;16:1376-83.
244. Rose AG, Holland WW, Crowley, EA. A sphygmomanometer for epidemiologist. Lancet 1964;I:296-300.
245. Lurbe E, Redon J, Kesani A et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 2002;347:797-805.
246. Liniger C, Favre L, Assal, JP. Twenty-four hour blood pressure and heart rate profiles of diabetic patients with abnormal cardiovascular reflexes. Diabet Med 1991;8:420-7.
247. Christensen CK, Mogensen CE. The course of incipient diabetic nephropathy: studies of albumin excretion and blood pressure. Diabet Med 1985;2:97-102.
248. Feldt-Rasmussen B, Mathiesen ER, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 1986:2:1300-04.
249. Armitage P, Rose GA. The variability of measurements of casual blood pressure I. A laboratory study. Clin Sci 1965;30:325-35.
250. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 2000;355:253-9.
251. Svensson P, de Faire U, Sleight P, Yusuf S, Ostergren J. Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy. Hypertension 2001;38:E28-E32.
252. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA 1983;249:2792-8.
253. Perloff D, Sokolow M, Cowan RM, Juster RP. Prognostic value of ambulatory blood pressure measurements: further analyses. J Hypertens 1989;(suppl 7):S3-S10.
254. Mann S, Millar Craig MW, Raftery EB. Superiority of 24-hour measurement of blood pressure over clinic values in determining prognosis in hypertension. Clin Exp Hypertens 1985;7(abstract):279-81.
255. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation 1998:98:1892-7.
256. Redon J. Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 1998;31:712-18.
257. Verdecchia P, Porcellati C, Schillaci G et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension (published erratum appears in Hypertension 1995;25[3]:462). Hypertension 1994;24:793-801.
258. Ohkubo T, Imai Y, Tsuji I, Nagai K, Ito S, Satoh H, Hisamichi S. Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: the Ohasama Study. Hypertension 1998;32:255-9.
259. Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755-62.
260. Janeway TC. The clinical study of blood-pressure. A guide to the use in in medical, surgical, and obstetrical practise, with a summary of the experimental and clinical facts relating to the blood-pressure in health and disease. New York, 1904.
261. Littler WA, Honour AJ, Carter RD, Sleight P. Sleep and blood pressure. BMJ 1975;3:346-8.
262. O'Brien E, Sheridan J, O'Malley K. Dippers and nondippers (letter). Lancet 1988;2:397.
263. Staessen JA, O'Brien ET, Amery AK et al. Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database. J Hypertens 1994;(suppl 12):S1-S12.
264. Baccelli G, Guazzi M, Mancia G, Zanchetti A. Neural and non-neural mechanisms influencing circulation during sleep. Nature 1969;223:184-5.
265. Mancia G, Zanchetti A. Cardiovascular regulation during sleep. In: Physiology in sleep. Orem J, Barnes CD (eds.). New York, Academic, 1980.
266. Wilcox CS, Aminoff MJ, Penn W. Basis of nocturnal polyuria in patients with autonomic failure. J Neurol Neurosurg Psychiatry 1974;37:677-84.
267. Mann S, Bellamy GR, Hunyor SN, Raftery EB, Ingall T, Bannister R. Supine hypertension, blood pressure variability and circadian rhythm in autonomic failure: the role of ambulatory intra-arterial monitoring. Clin Exp Pharmacol Physiol 1984;11:347-50.
268. Carvalho MJ, van den Meiracker AH, Boomsma F et al. Diurnal blood pressure variation in progressive autonomic failure. Hypertension 2000;35:892-7.
269. Reeves RA, Shapiro, AP, Thompson ME, Johnsen AM. Loss of nocturnal decline in blood pressure after cardiac transplantation. Circulation 1986;73:401-08.
270. Liniger C, Favre L, Adamec R, Pernet A, Assal JP. (Nyctohemeral arterial pressure profile and heart rate in autonomic diabetic neuropathy). Schweiz Med Wochenschr 1987;117:1949-53.
271. Hornung RS, Mahler RE, Raftery EB. Ambulatory blood pressure and heart rate in diabetic patients: an assessment of autonomic function. Diabet Med 1989;6:579-85.
272. Chamontin B, Barbe P, Begasse F, Ghisolfi A, Amar J, Louvet JP, Salvador M. (Ambulatory blood pressure in hypertension with dysautonomia). Arch Mal Coeur Vaiss 1990;83:1103-06.
273. Felici MG, Spallone V, Maiello MR et al. Twenty-four hours blood pressure and heart rate profiles in diabetics with and without autonomic neuropathy. Funct Neurol 1991;6:299-304.
274. Bauduceau B, Gautier D, Nizou C, Reboul P, Chanudet X, Larroque P. Role of nocturnal hypertension in the deterioration of diabetic nephropathy. Arch Mal Coeur Vaiss 1991;84:1105-09.
275. Spallone V, Bernardi L, Ricordi L et al. Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy. Diabetes 1993;42:1745-52.
276. Ikeda T, Matsubara T, Sato Y, Sakamoto N. Circadian blood pressure variation in diabetic patients with autonomic neuropathy. J Hypertens 1993;11:581-7.
277. Nielsen FS, Hansen HP, Jacobsen P et al. Increased sympathetic activity during sleep and nocturnal hypertension in Type 2 diabetic patients with diabetic nephropathy. Diabet Med 1999;16:555-62.
278. van Ittersum FJ. Blood pressure, arterial stiffness and autonomic function in insulin-dependent diabetes mellitus. Doctoral Thesis, Vrije Universiteit, Amsterdam, 2000.
279. Portaluppi F, Montanari L, Massari M, Di Chiara V, Capanna M. Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure. Am J Hypertens 1991;4:20-6.
280. Baumgart P, Walger P, Gerke M, Dorst KG, Vetter H, Rahn KH. Nocturnal hypertension in renal failure, haemodialysis and after renal transplantation. J Hypertens 1989;(suppl 7):S70-S71.
281. Torffvit O, Agardh CD. Day and night variation in ambulatory blood pressure in type 1 diabetes mellitus with nephropathy and autonomic neuropathy. J Intern Med 1993;233:131-7.
282. Hansen KW. Ambulatory blood pressure in insulin-dependent diabetes: the relation to stages of diabetic kidney disease. J Diabetes Complications 1996;10:331-51.
283. Dyrberg T, Benn J, Christiansen JS, Hilsted J, Nerup J. Prevalence of diabetic autonomic neuropathy measured by simple bedside tests. Diabetologia 1981;20:190-4.
284. Berglund J. Studies of cardiovascular and renal function in subclinical and manifest diabetic nephropathy. Acta Med Scand 1988;722(suppl):1-69.
285. Zander E, Schulz B, Heinke A, Grimmberger E, Zander G, Gottschling HD. Importance of cardiovascular autonomic dysfunction in IDDM subjects with diabetic nephropathy. Diabetes Care 1989;12:259-64.
286. Mulec H, Blohme G, Kullenberg K, Nyberg G, Bjorck S. Latent overhydration and nocturnal hypertension in diabetic nephropathy. Diabetologia 1995;38:216-20.
287. Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen B, Parving H-H. Circadian rhythm of arterial blood pressure and albuminuria in diabetic nephropathy. Kidney Int 1996;50:579-85.
288. Hansen KW, Sørensen K, Christensen PD, Pedersen EB, Christiansen JS, Mogensen CE. Night blood pressure: relation to organ lesions in microalbuminuric type 1 diabetic patients. Diabet Med 1995;12:42-5.
289. Nielsen FS, Rossing P, Bang LE, Svendsen TL, Gal MA, Smidt UM, Parving H-H. On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. Diabetes 1995;44:783-9.
290. Torbjörnsdottir T, Jaremko GA, Berg UB. Ambulatory blood pressure and heart rate in relation to kidney structure, function and metabolic control in adolescens with type 1 diabetes. In press, Diabetologia 2001.
291. Farmer CK, Goldsmith DJ, Quin JD et al. Progression of diabetic nephropathy-is diurnal blood pressure rhythm as important as absolute blood pressure level? Nephrol Dial Transplant 1998;13:635-9.
292. Pecis M, Azevedo MJ, Gross JL. Glomerular hyperfiltration is associated with blood pressure abnormalities in normotensive normoalbuminuric IDDM patients. Diabetes Care 1997;20:1329-33.
293. Gambardella S, Frontoni S, Spallone V et al. Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy (published erratum appears in Am J Hypertens 1993;6[12]:1066). Am J Hypertens 1993;6:97-102.
294. Guglielmi MD, Pierdomenico SD, Salvatore L et al. Impaired left ventricular diastolic function and vascular postischemic vasodilation associated with microalbuminuria in IDDM patients. Diabetes Care 1995;18:353-60.
295. Nielsen FS, Hansen HP, Jacobsen P et al. Increased sympathetic activity during sleep and nocturnal hypertension in Type 2 diabetic patients with diabetic nephropathy. Diabet Med 1999;16:555-62.